. . . . . . . . . . . . . . . . . . . "a(SCHEM:\"PD 98,059\") -| (p(HGNC:EGF) -> p(HGNC:MAPK3,pmod(P,T,202)))" . "p(HGNC:EGF) -> p(HGNC:MAPK3,pmod(P,T,202))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Pretreating the cells with aMAP2Kinhibitor, PD98059, decreased the MAPK3/2 phosphorylation induced by acrolein or EGF(Figure 3A). Pretreating the cells also decreased the levels of MUC5AC mRNA induced by acrolein or EGF (Figure 3B). " . . "Selventa" . . . . "2014-07-03T14:32:34.633+02:00"^^ . . .